Skip to main content
. 2020 May-Jun;84-85:73–79. doi: 10.1016/j.nucmedbio.2020.02.014

Fig. 2.

Fig. 2

(A) Calculation of the maximum specific binding (Bmax) and affinity (Kd) of anti-ICAM-1 antibody using flow cytometry, shows a 1.8-fold increase in Bmax value when comparing mock-treated to irradiated PSN-1 cells. (B) iTLC of 111In-labelled anti-ICAM-1 antibody, showing efficient conjugation of >95%. (C) The binding affinity of the anti-ICAM-1 DTPA/111In radio-conjugate ([111In]In-anti-ICAM-1), at 24 h time-point was determined using an in vitro saturation binding methodology. A negative control [111In]In-mIgG2a was also characterized.